If you have experienced symptoms of a transient ischemic attack (also known as a transient ischemic attack) or a mild ischemic stroke, your doctor may prescribe 300 mg of Clopidogrel (4 Clopidogrel SUN tablets) once at the beginning of treatment. After that, the recommended dose is one 75 mg Clopidogrel SUN tablet per day as described above with acetylsalicylic acid for 3 weeks. After that, your doctor will prescribe either Clopidogrel SUN alone or acetylsalicylic acid alone.
You should take Clopidogrel SUN for the time your doctor continues to prescribe it.
If you take moreClopidogrel SUNthan you should
Contact your doctor or go to the nearest hospital emergency department, as there is a higher risk of bleeding.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to takeClopidogrel SUN
If you forget to take a dose of Clopidogrel SUN, but remember before 12 hours have passed since the time you should have taken the medication, take the tablet immediately and the next one at the usual time.
If you forget for more than 12 hours, simply take the next dose at the usual time. Do not take a double dose to compensate for a missed tablet.
If you interrupt treatment withClopidogrel SUN
Do not stop your treatment unless your doctor tells you to. Contact your doctor or pharmacist before stopping this medication.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can have side effects, although not everyone will experience them.
Contact your doctor immediately if you experience:
- Fever, signs of infection, or severe fatigue. These symptoms may be due to a rare decrease in some blood cells.
- Signs of liver problems, such as yellowing of the skin and/or eyes (jaundice), associated or not with bleeding that appears under the skin as red spots and/or confusion (see section 2 "Warnings and precautions").
- Swelling of the mouth or skin disorders such as hives and itching, blisters on the skin. These may be signs of an allergic reaction.
The most frequent side effect reported with Clopidogrel SUNis bleeding. Bleeding can occur in the stomach or intestines, bruises, hematomas (abnormal bleeding or bruises under the skin), nasal bleeding, blood in urine. Also, a reduced number of cases of: bleeding of the blood vessels of the eyes, intracranial, pulmonary, or joint bleeding have been reported.
If you experience prolonged bleeding while taking Clopidogrel SUN
If you cut or get a wound, it is possible that bleeding will take a little longer than usual to stop. This is related to the mechanism of action of the medication, as it prevents the blood's ability to form clots. For minor cuts or wounds, such as cutting during shaving, this usually does not matter. However, if you are concerned about your bleeding, consult your doctor immediately (see section 2 "Warnings and precautions")
Other side effects include:
Frequent side effects (may affect up to 1 in 10 people)
Diarrhea, abdominal pain, indigestion, or heartburn.
Poorly frequent side effects(may affect up to 1 in 100 people)
Headache, stomach ulcer, vomiting, nausea, constipation, excessive gas in the stomach or intestines, rashes, itching, dizziness, numbness, and tingling.
Rare side effects (may affect up to 1 in 1,000 people)
Dizziness, breast enlargement in men.
Very rare side effects (may affect up to 1 in 10,000 people)
Jaundice, severe abdominal pain with or without back pain; fever, difficulty breathing, sometimes associated with cough; generalized allergic reactions (e.g., generalized feeling of heat with sudden general discomfort until fainting); swelling of the mouth; blisters on the skin, skin allergy; mouth pain (stomatitis); decreased blood pressure; confusion; hallucinations; joint pain; muscle pain; changes in taste or loss of taste of food.
Side effects of unknown frequency (cannot be estimated from available data):
Hypersensitivity reactions with chest or abdominal pain. Persistent symptoms of low blood sugar. In addition, your doctor may observe changes in your blood or urine test results.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the carton and in the Blister, after CAD. The expiration date is the last day of the month indicated.
This medication does not require special conditions for conservation.
Do not use this medication if you observe any visible signs of deterioration.
Medicines should not be thrown down the drains or in the trash. Dispose of the packaging and medicines you do not need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you do not need. In this way, you will help protect the environment.
Clopidogrel SUN Composition
- The active ingredient is clopidogrel. Each tablet contains 75 mg of clopidogrel (as hydrogen sulfate).
- The other components are:
Tablet core: mannitol, microcrystalline cellulose, macrogol 6000, hydrogenated castor oil, and low-substitution hydroxypropyl cellulose.
Tablet coating: Opadry II Pink 33K84841 (hypromellose, lactose, titanium dioxide, triacetin, iron oxide red).
Product Appearance and Packaging Content
Clopidogrel SUN 75 mg are film-coated, round, pink, biconvex, and smooth on both sides.
Clopidogrel SUN is presented in carton packs containing:
7, 10, 14, 20, 25, 28, 30, 50, 55, 56, 60, 84, 90, 98, 100, and 200 tablets in aluminum/PA/PVC/aluminum cold-form blisters.
Only some pack sizes may be commercially available.
Marketing Authorization Holder and Responsible Manufacturer
Marketing Authorization Holder:
Sun Pharmaceutical Industries Europe B.V.
Polarisavenue 87
2132JH Hoofddorp
Netherlands
Responsible Manufacturer:
Sun Pharmaceutical Industries Europe B.V.
Polarisavenue 87
2132JH Hoofddorp
Netherlands
or
Terapia SA
124 Fabricii Street
Cluj-Napoca, 400632
Romania
Local Representative
Sun Pharma Laboratorios, S.L.
Rambla de Catalunya 53-55
08007- Barcelona
Spain
Phone: + 34 93 342 78 90
This medicine is authorized in the following member states, with the following names:
Germany | Clopidogrel Basics 75 mg Filmtabletten |
Austria | Clopidogrel Ranbaxy 75 mg Filmtabletten |
Spain | Clopidogrel SUN 75 mg Film-coated Tablets EFG |
Poland | Clopidogrel Ranbaxy |
Romania | Clopidogrel Terapia 75 mg Coated Tablets |
Last reviewed date of this leaflet: September 2023
For detailed and updated information on this medicine, please visit the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.